Search PubMedSearch

PubMed · 7912833

Molecular modeling methods. Basic techniques and challenging problems.

Abstract

An overview is presented of computer modeling and simulation methods that play an increasing role in drug design: quantum chemical methods, molecular mechanics, molecular dynamics and Brownian dynamics. The application of molecular dynamics for the prediction of thermodynamic properties like free energy differences and binding constants is discussed. The Brownian dynamics method is presented in connection with the calculation of effective electrostatic forces using the Poisson-Boltzmann equation, which allows one to sample ligand-binding geometries and to predict the kinetics of diffusion-limited enzyme reactions. New techniques that have recently been extensively developed, such as the global energy minimization and quantum-classical dynamics methods, are also introduced. The molecular modeling methods are illustrated with selected examples.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B Lesyng, J A McCammon. 1993. Molecular modeling methods. Basic techniques and challenging problems.. https://doi.org/10.1016/0163-7258(93)90004-w

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and effects of granulocyte-macrophage colony-stimulating factor.

BACKGROUND: Neutropenic fever is the commonest complication of cladribine therapy for hairy-cell leukemia (HCL), leading to a 3% mortality rate. Our aim was to identify predictive factors and evaluate the effects of concomitant granulocyte-macrophage colony-stimulating factor (GM-CSF). PATIENTS AND METHODS: We studied 102 patients with active HCL given cladribine for 7 days. Pretreatment parameters predicting neutropenic fever were analysed. Twelve patients at high risk for febrile complications also received 400 micrograms GM-CSF per day on days 1 through 21. RESULTS: Pretreatment anemia, hypocholesterolemia, bone marrow differential with a high percentage of hairy cells and a low percentage of myelopoietic cells, low albumin, and high C-reactive protein predicted neutropenic fever. The addition of GM-CSF did not improve the kinetics of recovery for neutrophils, hemoglobin or platelets, as compared to matched control patients. However, GM-CSF significantly reduced cladribine-induced lymphopenia, but not the incidence of neutropenic fever. CONCLUSION: Factors predicting febrile neutropenia were identified. GM-CSF protected from cladribine lymphotoxicity but did not improve neutropenia or febrile episodes.

Cladribine